| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2459 | 2019 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2261 | 2006 |
| 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. S Meltzer, L Leiter, D Daneman, HC Gerstein, D Lau, S Ludwig, JF Yale, ... CMAJ: Canadian Medical Association Journal= Journal de l'Association …, 1998 | 693 | 1998 |
| Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease JF Yale, G Bakris, B Cariou, D Yue, E David‐Neto, L Xi, K Figueroa, ... Diabetes, Obesity and Metabolism 15 (5), 463-473, 2013 | 635 | 2013 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 570 | 2019 |
| S-1: The Insulin Receptor Kinase (IRK)-associated Phosphotyrosine phosphatase (PTP): A key regulator of IRK function and a therapeutic target BI Posner, JF Yale, A Shaver Experimental and Clinical Endocrinology & Diabetes 104 (S 02), 1-2, 1996 | 353 | 1996 |
| Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management LA Leiter, JF Yale, JL Chiasson, S Harris, P Kleinstiver, L Sauriol Can J Diabetes 29 (3), 186-192, 2005 | 331 | 2005 |
| SGLT2 inhibitor–associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis RM Goldenberg, LD Berard, AYY Cheng, JD Gilbert, S Verma, VC Woo, ... Clinical therapeutics 38 (12), 2654-2664. e1, 2016 | 325 | 2016 |
| Impact of a computer-based patient record system on data collection, knowledge organization, and reasoning VL Patel, AW Kushniruk, S Yang, JF Yale Journal of the American Medical Informatics Association 7 (6), 569-585, 2000 | 310 | 2000 |
| Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease JF Yale, G Bakris, B Cariou, J Nieto, E David‐Neto, D Yue, E Wajs, ... Diabetes, Obesity and Metabolism 16 (10), 1016-1027, 2014 | 291 | 2014 |
| A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin … HC Gerstein, JF Yale, SB Harris, M Issa, JA Stewart, E Dempsey Diabetic Medicine 23 (7), 736-742, 2006 | 275 | 2006 |
| Pharmacologic management of type 2 diabetes W Harper, M Clement, R Goldenberg, A Hanna, A Main, R Retnakaran, ... Canadian Journal of Diabetes 37, S61-S68, 2013 | 255 | 2013 |
| Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial JS Skyler, RS Weinstock, P Raskin, JF Yale, E Barrett, JE Gerich, ... Diabetes care 28 (7), 1630-1635, 2005 | 253 | 2005 |
| Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes V Papademetriou, L Lovato, M Doumas, E Nylen, A Mottl, RM Cohen, ... Kidney international 87 (3), 649-659, 2015 | 243 | 2015 |
| Diabetes and mental health DJ Robinson, M Coons, H Haensel, M Vallis, JF Yale, ... Canadian journal of diabetes 42, S130-S141, 2018 | 228 | 2018 |
| Type 2 diabetes mellitus management in Canada: is it improving? LA Leiter, L Berard, CK Bowering, AY Cheng, KG Dawson, JM Ekoé, ... Canadian journal of diabetes 37 (2), 82-89, 2013 | 202 | 2013 |
| Effect of acarbose on insulin sensitivity in elderly patients with diabetes. GS Meneilly, EA Ryan, J Radziuk, DC Lau, JF Yale, J Morais, ... Diabetes care 23 (8), 1162-1167, 2000 | 197 | 2000 |
| Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease MS Goldberg, RT Burnett, JF Yale, MF Valois, JR Brook Environmental research 100 (2), 255-267, 2006 | 173 | 2006 |
| Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial MD Sullivan, WJ Katon, LC Lovato, ME Miller, AM Murray, KR Horowitz, ... JAMA psychiatry 70 (10), 1041-1047, 2013 | 171 | 2013 |
| Hypoglycemia JF Yale, B Paty, PA Senior, ... Canadian journal of diabetes 42, S104-S108, 2018 | 164 | 2018 |
